John D. Baxter

Rate of response to initial antiretroviral therapy according to level of pre‐existing HIV‐1 drug resistance detected by next‐generation sequencing in the strategic timing of antiretroviral treatment (START) study

M. Kozal, A. Tostevin, M. Gompels, 2023, HIV Medicine.

Global HIV‐1 transmitted drug resistance in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

A. Geretti, J. Llibre, S. Jacoby, 2015, HIV medicine.